Servicio de Nefrología, Hospital General Universitario de Alicante, España.
Servicio de Farmacia Hospitalaria, Hospital General Universitario de Alicante, España.
Nefrologia (Engl Ed). 2020 Jan-Feb;40(1):32-37. doi: 10.1016/j.nefro.2019.04.010. Epub 2019 Aug 12.
Currently, kidney transplantation is the treatment of choice for patients with kidney disease who require replacement therapy. Dialysis is a necessary step, but not mandatory prior to transplantation. There is the possibility of pre-emptive transplantation or transplantation in pre-dialysis, that is, without previous dialysis. The aim of the present study is to evaluate the result of our experience with a pre-emptive kidney transplant from a deceased donor.
Retrospective, observational, matched cohort study. We compared 66 pre-emptive with 66 non pre-emptive recipients, who received a first renal graft performed at our centre, matched by age and gender of donors and recipients, time of transplant, immunological risk, immunosuppression and cold ischaemia time. Early graft loss, incidence of acute rejection, delayed graft function, renal function at 12 and 36 months and graft and recipient survival were assessed in this period.
The percentage of recipients who presented early graft loss, delayed graft function and acute rejection was similar in both groups. No differences were observed in their renal function at 12 and 36 months after transplantation, as well as the actuarial survival of patients (P=0.801) and grafts (P=0.693) in the studied period. The total calculated cost of the period on dialysis for the control group was 8,033,893.16 euros.
Pre-emptive transplantation can yield comparable outcomes to those for post-dialysis kidney transplantation, and results in better quality of life for patients with end-stage kidney disease, as well as a reduced cost.
目前,对于需要替代治疗的肾病患者,肾移植是首选治疗方法。透析是必要的步骤,但并非移植前的强制性步骤。存在抢先移植或在透析前移植的可能性,即在没有先前透析的情况下进行移植。本研究旨在评估我们对来自已故供体的抢先肾移植的经验结果。
回顾性、观察性、匹配队列研究。我们比较了 66 例抢先移植和 66 例非抢先移植的受者,这些受者在我们中心接受了首次肾移植,供体和受者的年龄和性别、移植时间、免疫风险、免疫抑制和冷缺血时间相匹配。在此期间评估了早期移植物丢失、急性排斥反应发生率、延迟移植物功能、12 个月和 36 个月时的肾功能以及移植物和受者存活率。
两组患者的早期移植物丢失、延迟移植物功能和急性排斥反应的发生率相似。移植后 12 个月和 36 个月时,两组患者的肾功能无差异,研究期间患者(P=0.801)和移植物(P=0.693)的存活率也无差异。对照组在透析期间的总计算费用为 8033893.16 欧元。
抢先移植可以获得与透析后肾移植相当的结果,并为终末期肾病患者带来更好的生活质量,同时降低成本。